Form 4 for NKTR NEKTAR THERAPEUTICS
Accepted 2021-09-24 00:00:00 ET · period of report 2021-09-22 · accession 0001209191-21-057706 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-24 | 2021-09-22 | NKTR | EASTHAM KARIN | Dir | A - Grant | $0.00 | +10.2K | 34.3K | +42% | $0 |
| D | 2021-09-24 | 2021-09-22 | NKTR | EASTHAM KARIN | Dir | A - Grant | $0.00 | +20.4K | 20.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-22 | A | A | 10,200 | $0.00 | 34,300 | D | — | — | (F1) Common stock was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock. |
| 2 | Derivative | Stock Option | 2021-09-22 | A | A | 20,400 | $0.00 | 20,400 | D | $17.78 · — to 2029-09-21 | 20,400 Common Stock | (F3) This stock option vests in equal monthly installments over the one-year period beginning on September 22, 2021. |